{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:18:48Z","timestamp":1789683528081,"version":"4.0.1"},"reference-count":51,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,13]]},"DOI":"10.20945\/2359-4292-2022-0138","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:44:46Z","timestamp":1699983886000},"source":"Crossref","is-referenced-by-count":6,"title":["Histological findings and NAFLD\/NASH Status in liver biopsies of patients subjected to bariatric surgery"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-4963","authenticated-orcid":false,"given":"Marielle","family":"Malucelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-2613","authenticated-orcid":false,"given":"Rodrigo","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-557X","authenticated-orcid":false,"given":"Claudia","family":"Ivantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3536-8262","authenticated-orcid":false,"given":"Danielle","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-9332","authenticated-orcid":false,"given":"M\u00e1rcio Lu\u00eds","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-3402","authenticated-orcid":false,"given":"Maria Lucia Alves","family":"Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"7","key":"key20231114124439_B1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158(7):1851-64. doi: 10.1053\/j.gastro.2020.01.052.","journal-title":"Gastroenterology"},{"issue":"1","key":"key20231114124439_B2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza","year":"2012","unstructured":"Souza MRA, Diniz MFFM, Medeiros-Filho JEM, Ara\u00fajo MST. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012;49(1):89-96. doi: 10.1590\/s0004-28032012000100015.","journal-title":"Arq Gastroenterol"},{"key":"key20231114124439_B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Quentin MA, Juan PA, Rachel LB, Laurent C, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:61. doi: 10.1038\/s41575-021-00523-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"key20231114124439_B4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Kiarash","year":"2022","unstructured":"Kiarash R, Hassan A, Jacob HC, Fox EU, James AK, Elnaz EA, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851-61. doi: 10.1016\/S2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"key20231114124439_B5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20. doi: 10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"key20231114124439_B6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5694\/mja2.51096","article-title":"Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study","volume":"215","author":"Roberts","year":"2021","unstructured":"Roberts SK, Majeed A, Glenister K, Magliano D, Lubel JS, Bourke L, et al. Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. Med J Aust. 2021;215(2):77-82. doi: 10.5694\/mja2.51096.","journal-title":"Med J Aust"},{"issue":"6","key":"key20231114124439_B7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of nonalcoholic fatty liver: a follow-up study","volume":"22","author":"Teli","year":"1995","unstructured":"Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995;22(6):1714-9.","journal-title":"Hepatology"},{"issue":"1","key":"key20231114124439_B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","article-title":"Clinical features and natural history of nonalcoholic steatosis syndromes","volume":"21","author":"Falck-Ytter","year":"2001","unstructured":"Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21(1):17-26. doi: 10.1055\/s-2001-12926.","journal-title":"Semin Liver Dis"},{"issue":"6","key":"key20231114124439_B9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413-9. doi: 10.1016\/s0016-5085(99)70506-8.","journal-title":"Gastroenterology"},{"issue":"9793","key":"key20231114124439_B10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804-14. doi: 10.1016\/S0140-6736(11)60813-1.","journal-title":"Lancet"},{"issue":"4","key":"key20231114124439_B11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? J Hepatol. 2022;76(4):771-80. doi: 10.1016\/j.jhep.2021.10.025.","journal-title":"J Hepatol"},{"issue":"11","key":"key20231114124439_B12","first-page":"2714","article-title":"Nonalcoholic steatohepatitis: what we know in the new millennium","volume":"97","author":"Harrison","year":"2002","unstructured":"Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol. 2002;97(11):2714-24. doi: 10.1111\/j.1572-0241.2002.07069.x.","journal-title":"Am J Gastroenterol"},{"key":"key20231114124439_B13","first-page":"12","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"14","author":"Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;14:12-60. doi: 10.1186\/s13098-020-00570-y.","journal-title":"Diabetol Metab Syndr"},{"key":"key20231114124439_B14","first-page":"i","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3","key":"key20231114124439_B15","first-page":"257","article-title":"Gastrointestinal Surgery for Severe Obesity","volume":"1","author":"Hubbard","year":"1991","unstructured":"Hubbard VS, Hall WH. Gastrointestinal Surgery for Severe Obesity. Obesity Surgery. 1991;1(3):257-65. doi: 10.1381\/096089291765560962.","journal-title":"Obesity Surgery"},{"key":"key20231114124439_B16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13098-017-0251-z","article-title":"Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)","volume":"9","author":"Bertoluci","year":"2017","unstructured":"Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetol Metab Syndr. 2017;9:53. doi: 10.1186\/s13098-017-0251-z.","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"key20231114124439_B17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2013 a new world \u2013 wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome \u2013 a new world \u2013 wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80. doi: 10.1111\/j.1464-5491.2006.01858.x.","journal-title":"Diabet Med"},{"key":"key20231114124439_B18","first-page":"45","volume-title":"Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica","author":"Cotrim","year":"2011","unstructured":"Cotrim HP, Rocha R. Doen\u00e7a Hep\u00e1tica Gordurosa N\u00e3o Alco\u00f3lica, Esteato-Hepatite e suas Correla\u00e7\u00f5es. In: Galizzi Filho J, Cotrim HP, Parise ER, Oliveira C, editores. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica. 2011. p. 45-55."},{"issue":"6","key":"key20231114124439_B19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1590\/2359-3997000000306","article-title":"Thyroid disorders in obese patients. Does insulin resistance make a difference?","volume":"61","author":"R\u0103c\u0103t\u0103ianu","year":"2017","unstructured":"R\u0103c\u0103t\u0103ianu N, Leach N, Bondor CI, M\u00e2rza S, Moga D, Valea A, et al. Thyroid disorders in obese patients. Does insulin resistance make a difference? Arch Endocrinol Metab. 2017;61(6):575-83. doi: 10.1590\/2359-3997000000306.","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"key20231114124439_B20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-21. doi: 10.1002\/hep.20701.","journal-title":"Hepatology"},{"issue":"8","key":"key20231114124439_B21","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s10620-007-0109-6","article-title":"Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol","volume":"53","author":"Merat","year":"2008","unstructured":"Merat S, Aduli M, Kazemi R, Sotoudeh M, Sedighi N, Sohrabi M, et al. Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. Dig Dis Sci. 2008;53(8):2246-50. doi: 10.1007\/s10620-007-0109-6.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"key20231114124439_B22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. doi: 10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"12","key":"key20231114124439_B23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-115-12-956","article-title":"Gastrointestinal surgery for severe obesity","volume":"115","author":"National Institutes of Health Consensus Development conference statement","year":"1991","unstructured":"National Institutes of Health Consensus Development conference statement. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956-61.","journal-title":"Ann Intern Med"},{"issue":"11","key":"key20231114124439_B24","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00464-007-9351-4","article-title":"Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients","volume":"21","author":"Kroh","year":"2007","unstructured":"Kroh M, Liu R, Chand B. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. Surg Endosc. 2007;21(11):1957-60. doi: 10.1007\/s00464-007-9351-4.","journal-title":"Surg Endosc"},{"key":"key20231114124439_B25","first-page":"1","volume-title":"Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica","author":"Galizzi","year":"2011","unstructured":"Galizzi Filho J. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica (DHGNA). In: Galizzi Filho J, Cotrim HP, Parise ER, Oliveira C, editores. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica. 2011. p. 1-12."},{"key":"key20231114124439_B26","first-page":"27","volume-title":"Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica","author":"Ferrari","year":"2011","unstructured":"Ferrari TCA, Lima M, Galizzi Filho J. Epidemiologia da doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica. In: Galizzi Filho J, Cotrim HP, Parise ER, Oliveira C, editores. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica. 2011. p. 27-33."},{"issue":"2","key":"key20231114124439_B27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","unstructured":"Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol. 2007;102(2):399-408. doi: 10.1111\/j.1572-0241.2006.01041.x.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"key20231114124439_B28","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1381\/096089206779319392","article-title":"Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease","volume":"16","author":"Liew","year":"2006","unstructured":"Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg. 2006;16(12):1584-93. doi: 10.1381\/096089206779319392.","journal-title":"Obes Surg"},{"issue":"11","key":"key20231114124439_B29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00042737-200411000-00002","article-title":"The epidemiology of fatty liver","volume":"16","author":"Bellentani","year":"2004","unstructured":"Bellentani S, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. Eur J Gastroenterol Hepatol. 2004;16(11):1087-93. doi: 10.1097\/00042737-200411000-00002.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"key20231114124439_B30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","unstructured":"Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol. 2012;18(3):237-43. doi: 10.3748\/wjg.v18.i3.237.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"key20231114124439_B31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31584-4","article-title":"Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile","volume":"10","author":"Cotrim","year":"2011","unstructured":"Cotrim HP, Parise ER, Oliveira CPMS, Leite N, Martinelli A, Galizzi J, et al. Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. Ann Hepatol. 2011;10(1):33-7.","journal-title":"Ann Hepatol"},{"issue":"6","key":"key20231114124439_B32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S1516-31802007000600006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults","volume":"125","author":"Karnikowski","year":"2007","unstructured":"Karnikowski M, C\u00f3rdova C, Oliveira RJ, Karnikowski MGO, N\u00f3brega OT. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J. 2007;125(6):333-7. doi: 10.1590\/s1516-31802007000600006.","journal-title":"Sao Paulo Med J"},{"issue":"6","key":"key20231114124439_B33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95. doi: 10.1002\/hep.20466.","journal-title":"Hepatology"},{"issue":"3","key":"key20231114124439_B34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52(3):913-24. doi: 10.1002\/hep.23784.","journal-title":"Hepatology"},{"key":"key20231114124439_B35","first-page":"311","volume-title":"Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica","author":"Cotrim","year":"2011","unstructured":"Cotrim HP, Andrade ACR. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica e obesidade grave. In: Galizzi Filho J, Cotrim FP, Parise ER, Oliveira C, editores. Doen\u00e7a hep\u00e1tica gordurosa n\u00e3o alco\u00f3lica. 2011. p. 311-21."},{"issue":"5","key":"key20231114124439_B36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","article-title":"Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease","volume":"139","author":"Chalasani","year":"2010","unstructured":"Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, Kwon S, et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology. 2010;139(5):1567-76, 1576.e1-6. doi: 10.1053\/j.gastro.2010.07.057.","journal-title":"Gastroenterology"},{"issue":"4","key":"key20231114124439_B37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.sla.0000179652.07502.3f","article-title":"Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome","volume":"242","author":"Mattar","year":"2005","unstructured":"Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242(4):610-7; discussion 618-20. doi: 10.1097\/01.sla.0000179652.07502.3f.","journal-title":"Ann Surg"},{"issue":"9","key":"key20231114124439_B38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/oby.2009.89","article-title":"Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort","volume":"17","author":"Kashyap","year":"2009","unstructured":"Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, Gray-McGuire C, et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring). 2009;17(9):1696-701. doi: 10.1038\/oby.2009.89.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"key20231114124439_B39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-5996-3-3","article-title":"New clinical score to diagnose nonalcoholic steatohepatitis in obese patients","volume":"3","author":"Pulzi","year":"2011","unstructured":"Pulzi FB, Cisternas R, Melo MR, Ribeiro CM, Malheiros CA, Salles JE. New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol Metab Syndr. 2011;23;3(1):3. doi: 10.1186\/1758-5996-3-3.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"key20231114124439_B40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11695-011-0559-y","article-title":"Effect of bariatric surgery on liver fibrosis","volume":"22","author":"Moretto","year":"2012","unstructured":"Moretto M, Kupski C, da Silva VD, Padoin AV, Mottin CC. Effect of bariatric surgery on liver fibrosis. Obes Surg. 2012;22(7):1044-9. doi: 10.1007\/s11695-011-0559-y.","journal-title":"Obes Surg"},{"issue":"4","key":"key20231114124439_B41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","unstructured":"Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care. 2012;35(4):873-8. doi: 10.2337\/dc11-1849.","journal-title":"Diabetes Care"},{"issue":"3","key":"key20231114124439_B42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/hep.24483","article-title":"Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis","volume":"54","author":"Lomonaco","year":"2011","unstructured":"Lomonaco R, Ortiz-Lopez C, Orsak B, Finch J, Webb A, Bril F, et al. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology. 2011;54(3):837-45. doi: 10.1002\/hep.24483.","journal-title":"Hepatology"},{"issue":"5","key":"key20231114124439_B43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1381\/096089204323093408","article-title":"The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients","volume":"14","author":"Mottin","year":"2004","unstructured":"Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14(5):635-7. doi: 10.1381\/096089204323093408.","journal-title":"Obes Surg"},{"issue":"5","key":"key20231114124439_B44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.orcp.2021.09.002","article-title":"Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study","volume":"15","author":"Leivas","year":"2021","unstructured":"Leivas G, Maraschin CK, Blume CA, Telo GH, Trindade MRM, Trindade EN, et al. Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study. Obes Res Clin Pract. 2021;15(5):461-5. doi: 10.1016\/j.orcp.2021.09.002.","journal-title":"Obes Res Clin Pract"},{"issue":"10","key":"key20231114124439_B45","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.cgh.2012.06.019","article-title":"Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients","volume":"10","author":"Francque","year":"2012","unstructured":"Francque SMA, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol. 2012;10(10):1162-8; quiz e87. doi: 10.1016\/j.cgh.2012.06.019.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"key20231114124439_B46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3329\/jbcps.v25i3.411","article-title":"Non Alcoholic Fatty Liver Disease - Is It Always Benign?","volume":"25","author":"Rahman","year":"2007","unstructured":"Rahman MM, Abedin T, Amin R, Rahman MR, Faiz MA. Non Alcoholic Fatty Liver Disease - Is It Always Benign? J Bangladesh Coll Phys. 2007;25(3):144-52.","journal-title":"J Bangladesh Coll Phys"},{"issue":"5","key":"key20231114124439_B47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau","year":"1999","unstructured":"Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84(5):1513-7. doi: 10.1210\/jcem.84.5.5661.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20231114124439_B48","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11695-009-0027-0","article-title":"Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass","volume":"20","author":"Guajardo-Salinas","year":"2010","unstructured":"Guajardo-Salinas GE, Hilmy A. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Obes Surg. 2010;20(12):1647-53. doi: 10.1007\/s11695-009-0027-0.","journal-title":"Obes Surg"},{"key":"key20231114124439_B49","first-page":"2784537","article-title":"Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis","author":"Li","year":"2018","unstructured":"Li B, Zhang C, Zhan YT. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Can J Gastroenterol Hepatol. 2018:2784537. doi: 10.1155\/2018\/2784537.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"8","key":"key20231114124439_B50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.5858\/arpa.2021-0339-RA","article-title":"Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease","volume":"146","author":"Lai","year":"2022","unstructured":"Lai J, Wang HL, Zhang X, Wang H, Liu X. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease. Arch Pathol Lab Med. 2022;146(8):940-6. doi: 10.5858\/arpa.2021-0339-RA.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"key20231114124439_B51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1665-2681(19)31748-X","article-title":"NASH and cryptogenic cirrhosis: a histological analysis","volume":"8","author":"Caldwell","year":"2009","unstructured":"Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, Northup PG, et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol. 2009;8(4):346-52.","journal-title":"Ann Hepatol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:45:10Z","timestamp":1699983910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/histological-findings-and-nafld-nash-status-in-liver-biopsies-of-patients-subjected-to-bariatric-surgery\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":51,"alternative-id":["10.20945\/2359-4292-2022-0138"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2022-0138","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"article-number":"e220138"}}